A training titled: “Managing a research project” has been held today by STREAMLINE partners from Centre for Research & Technology Hellas (CERTH), Greece. IMGGE researchers got guidelines and important practical advices regarding to the management of EU-funded research projects. The training covered many important topics including monitoring of project progress, risk management, documentation and reporting etc. We use the opportunity to thank Dr. Spyros Petrakis and Ms Athina Karachaliou for organizing the event and sharing their experience with IMGGE team.
A two-day training session was held last week. A team of experts from the University of Maastricht (UM) held a series of practical lectures. The training was dedicated to data protection and data sharing in biomedical research. To apply the gained knowledge, the IMGGE researchers had to solve some practical tasks that include answering the given questions and presenting a case study to the experts from UM. Under experts’ supervision and guidance , IMGGE researchers improved their knowledge in this very important area. Our sincere gratitude to Dorothee Horstkötter, Helena Bossini Castillo, and Birgit Wouters for the wonderful training and great experience.
Under the umbrella of the STREAMLINE project, our partners from CERTH Dr. Spyros Petrakis and Mr. Dimitris Kaboukos opened a series of lectures on the following topic: Proposal preparation for EU calls. We have the opportunity to meet the requirements of EU funding programs, learn about the planning of research projects and call documents. Moreover, we have been given the guidelines to make it simpler for us to understand the application paperwork. At the very end, we shared experiences that researchers face during Budget preparation.
We would like to announce the symposium “Microdeletion 22q11.2 – together towards better understanding and treatment” that will be held at University Children’s Hospital, Tirsova 10, Belgrade on December 9, 2022. The Symposium will bring together patients with 22q11.2 Deletion Syndrome, their families and experts from different fields (clinical geneticists, molecular biologists, cardiologists, cardiac surgeons, psychiatrists, logopedists). It will cover topics about the latest achievements in the field of studying the 22q11.2 Deletion Syndrome and neurodevelopmental disorders. Patient organizations will take part in the Symposium and they will share their experiences with the symposium participants.